MedTrace Logo

Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer Patients

NCT02376413 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-12-03

No results posted yet for this study

Summary

Breast-conserving surgery (BCS) is the traditional surgical treatment for early-stage breast cancer patients. There are evidences indicating that oncoplastic-BCS (displacement technique) could improve cosmetic outcomes and/or quality of life, and has similar oncological safety as traditional BCS does. However, there are no prospective trial comparing oncoplastic-BCS vs. traditional BCS in terms of cosmetic outcomes and oncological safety. In this study, the investigators are going to address this issue by assigning patients into traditional and oncoplastic-BCS group, based on their preference.

Conditions

  • Local Recurrence of Malignant Tumor of Breast

Interventions

PROCEDURE

Breast surgery

Traditional breast-conserving surgery, oncoplastic breast-conserving surgery or modified radical mastectomy

DRUG

Chemotherapy or endocrine therapy or Trastuzumab therapy

RADIATION

Radiation therapy

Sponsors & Collaborators

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    lead OTHER

Principal Investigators

  • Erwei Song, M.D. Ph.D. · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

  • Fengxi Su, M.D. · Yat-sen Memorial Hospital, Sun Yat-sen University.

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2022-03-31
Completion
2022-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02376413 on ClinicalTrials.gov